Evidence map›Paper›PMID 42438296›Full record

ArticleEuropean journal of neurology2026

A Novel RORA Hinge-Region Variant in Adult IDDECA With Cerebellar Atrophy and Marked Response to Valproate.

V Busco, G Di Lazzaro, A T Cimmino, F Bove, L Saccinto, G Silvestri, A R Bentivoglio

Abstract readCase Reports
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

V BuscoUniversità Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0009-0005-1159-0258
G Di LazzaroUniversità Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0000-0003-2413-1788
A T CimminoUniversità Cattolica del Sacro Cuore, Rome, Italy.
F BoveUniversità Cattolica del Sacro Cuore, Rome, Italy.
L SaccintoR&I Genetics, Padova, Italy.
G SilvestriUniversità Cattolica del Sacro Cuore, Rome, Italy.
A R BentivoglioUniversità Cattolica del Sacro Cuore, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo expand the RORA mutational and clinical spectrum by reporting a novel hinge-region variant associated with an adult progressive phenotype and a marked therapeutic response to valproate.

methodsWe describe a 61-year-old woman with lifelong intellectual disability who developed subacute severe motor deterioration in adulthood. Evaluation included brain MRI and whole-exome sequencing.

resultsWhole-exome sequencing identified a novel heterozygous variant, c.551C>G (p.Pro184Arg), in the hinge region (domain D) of RORA, a region not previously implicated in human disease. While RORA-related disorders are typically described as neurodevelopmental conditions, our patient showed progressive motor decline with loss of independent ambulation. Brain MRI demonstrated marked vermian atrophy, supporting a possible progressive component. Withdrawal of valproate was followed by severe clinical worsening, whereas reintroduction led to marked improvement in tremor and gait, restoring independent ambulation. DISCUSSION: This case expands the mutational and phenotypic spectrum of RORA-related disorders and suggests that hinge-region variants may contribute to a more severe phenotype. It also supports a role for cortical hyperexcitability in the motor manifestations and highlights a potentially treatable component, with implications for clinical management.

Indexed as

CerebellumIntellectual DisabilityValproic AcidAtrophyFemaleHumansMiddle AgedValproic Acidcerebellar ataxiacerebellar atrophycortical myoclonusIDDECAintellectual disabilityneurogeneticsRORAvalproate

Identifiers

PMID42438296
PMCPMC13358359

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.